CD8A and neoplasm: To become tumor-specific CD8+ T-cells, naïve CD8+ T-cells in the draining lymph nodes are presented with TAAs in the context of the major histocompatibility complex (MHC) class I molecules by professional antigen-presenting cells (APCs), particularly DCs [25].